A complete application in a minute
Tailored resume and cover letter, ready to send.
Takeda is seeking a Lead Clinical Study Manager to drive the operational strategy and execution of clinical studies across assigned programmes. You will lead cross-functional study teams and partner with internal stakeholders and vendors to ensure high-quality, compliant studies delivered on time and within budget.
You will chair the Study Execution Team, oversee CROs and partners, and provide input into study protocols.
At Takeda, we are united by our purpose of creating better health for people and a brighter future for the world. We are seeking a Lead Clinical Study Manager (Lead CSM) to drive the operational strategy and execution of clinical studies across assigned programmes.
In this role, you will lead cross‑functional study teams and partner closely with internal stakeholders and external vendors to ensure delivery of clinical studies that are high quality, compliant, and executed on time and within budget. This is a critical role supporting Takeda’s global clinical development strategy.
We offer a truly collaborative, purpose‑driven environment where innovation, integrity, and patient focus are at the heart of everything we do. This role follows a hybrid working model to support both flexibility and team collaboration.
At Takeda, we are committed to fostering a diverse, equitable, and inclusive environment where every individual can thrive. We believe that diversity of backgrounds, perspectives, and experiences drives innovation and strengthens our ability to deliver for patients. We welcome applications from all qualified candidates and are dedicated to creating an inclusive workplace where everyone feels valued, respected, and empowered to achieve their full potential.
Takeda is an equal opportunity employer.
If you are limited in the ability to use our job application tool, or otherwise require a reasonable accommodation for a disability.
Takeda is a global, values‑based, R&D‑driven biopharmaceutical leader headquartered in Japan, committed to advancing innovative medicines across gastroenterology, rare diseases, plasma‑derived therapies, oncology, neuroscience, and vaccines.